Literature DB >> 31606283

Reproductive and Hormonal Considerations in Women at Increased Risk for Hereditary Gynecologic Cancers: Society of Gynecologic Oncology and American Society for Reproductive Medicine Evidence-Based Review.

Lee-May Chen1, Stephanie V Blank2, Elizabeth Burton3, Karen Glass4, Emily Penick5, Terri Woodard6.   

Abstract

Providers who care for women at risk for hereditary gynecologic cancers must consider the impact of these conditions on reproductive and hormonal health. This document reviews potential options for cancer prevention, family building, genetic testing and management of surgical menopause in this patient population. Capsule: Women predisposed to hereditary gynecologic cancer have options for fertility preservation, preimplantation genetic testing to select embryos without pathogenic variants, pregnancy through gestational carriers after hysterectomy and hormone replacement.
Copyright © 2019 Elsevier Inc., American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Endometrial cancer; Genetic counseling; Menopause and hormone replacement therapy; Ovarian cancer; Quality of life issues

Mesh:

Year:  2019        PMID: 31606283     DOI: 10.1016/j.ygyno.2019.06.017

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  3 in total

1.  Vaginal cuff dehiscence following transvaginal oocyte retrieval: a case report.

Authors:  Sarah K O'Connor; David A Ryley; Charles W Obasiolu; Katharine M Esselen; Christine C Skiadas; Wendy Kuohung
Journal:  Fertil Res Pract       Date:  2020-09-02

2.  Cost-effectiveness Analysis of Genotype-Specific Surveillance and Preventive Strategies for Gynecologic Cancers Among Women With Lynch Syndrome.

Authors:  Jason D Wright; Elisabeth R Silver; Sarah Xinhui Tan; Chin Hur; Fay Kastrinos
Journal:  JAMA Netw Open       Date:  2021-09-01

Review 3.  Hereditary Gynecologic Cancer Syndromes - A Narrative Review.

Authors:  Stoyan Kostov; Rafał Watrowski; Yavor Kornovski; Deyan Dzhenkov; Stanislav Slavchev; Yonka Ivanova; Angel Yordanov
Journal:  Onco Targets Ther       Date:  2022-04-08       Impact factor: 4.147

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.